Full Text
PEY17 COST-EFFECTIVENESS OF PEGAPTANIB IN AGE-RELATED MACULAR DEGENERATION- IMPACT OF DIFFERENCES BETWEEN US AND UK HEALTH CARE SYSTEMS

Abstract

Authors

J Javitt S Wolowacz N Roskell S Maciver S Kelly A Pleil G Zlateva

Back to Volume 9, Issue 6
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×